Genovis ramps up in ADC technology: “An area where we’re seeing very strong interest”

With new products and an expanded licensing agreement in hand Genovis now has a partly new focus for its operations: ADCs – or antibody‑drug conjugates.

End of bone‑sawing? New laser cuts to record depths

Saw, drill and chisel are a bone surgeon’s best friends today – but soon the laser may also find its place in that toolbox. Researchers in Switzerland have disc...

Lungforskningsbolag kan andas ut efter fulltecknad nyemission

Medicinteknikbolaget Pexa har beslutat att upprätta kontrollbalansräkning – men genomför också en fullt garanterad företrädesemission för att återupprätta sitt aktiekapital.

Swedish drug development projects in Phase III – studies to keep an eye on

Developing new medicines is, as we know, a lengthy and uncertain process, and only a fraction of all projects ever reach late clinical phase. But it does happen...

How Microscopy Can Help Families Grow

Advanced microscopy solutions can help bypass challenges and natural barriers of conception.

Season 2 of ZEISS Metrology Expert Tips is now live

Experts from season 1 compete against each other in #measuringhero quiz.

Breakthrough devices: Key insights from MDCG 2025-9 guidance

The Medical Device Coordination Group (MDCG) has published guidance MDCG 2025-9 to streamline the pathway for breakthrough devices (BtX) under the EU Medical De...

Dying man saved by artificial lung system

An external artificial lung system kept a critically ill man alive for two days until he could undergo a lung transplant. In the longer term, researchers hope t...

Finland leads the way in the hunt for international top researchers

Several Nordic initiatives are currently under way to recruit international top researchers. Finland is making its largest national investment ever in attractin...

Novo Nordisk Foundation commits billions to Danish life science incubator

The Novo Nordisk Foundation grants up to DKK 5.5 billion to life science and deep‑tech incubator Bioinnovation Institute (BII) in Copenhagen.

Clinical evaluation of class I medical devices

The Swedish Medtech Regulatory Summit is just around the corner — taking place on March 12th at Hilton Slussen in Stockholm. We’re proud to share that our Senio...

Explore 3D Testing of Deformation and Motions

Powerful measurement capabilities with the new ZEISS ARAMIS 1.

A cluster contribution to European life science innovation and competitiveness?

Webinar: Imaging of Complex In-Vitro Models

Deep Imaging and Scalable Analysis of Hepatic Spheroids with ZEISS LSM 910/990 Lightfield 4D.

Top 10 biggest drug launches 2026

Two presumed sales rockets – both in obesity and type 2 diabetes – top a list of potential blockbusters expected to launch in the United States in 2026.

Multicancer test failed to meet its goal – shares plunged

A blood test designed to detect multiple types of cancer failed to meet its primary endpoint in a large UK study. The company behind the test saw its market value cut in half.

Atrogi on its challenger to GLP-1: “Now we are stepping forward”

A new approach to treating type 2 diabetes and obesity is taking shape in a laboratory just a stone’s throw from the Karolinska Institute. At Atrogi, researcher...

Cell-free cartilage from Lund could pave the way for new bone transplants

Researchers at Lund University have developed a new method for repairing large bone defects, based on laboratory-engineered, cell-free cartilage grafts. The tec...

“The US matters most – even in times of turbulence”

Tariffs, geopolitical uncertainty and rapidly changing trade conditions mean that Swedish life science companies need more routes into global markets – and fast...

Study: Autism as common in girls as in boys

Autism may be just as common in girls as in boys, but girls are diagnosed significantly later and less often during childhood, according to a large Swedish registry study.

Webinar: Fast and Gentle Imaging of Developing Human Spinal Cord Organoids with ZEISS Lattice Lights

Imaging of complex in-vitro models.

Investor Network Backs Early-Stage Nordic Innovation

Life Science Invest is expanding into the Nordic region and has secured SEK 31 million to invest in early-stage research companies. The capital will be invested...

Obesity dominates as future blockbusters are identified

Two drug candidates targeting obesity and diabetes stand out sharply in Clarivate’s newly selected “starting eleven” of potential future blockbusters worth watching.

Ett år efter avbruten GPL-1-behandling – nästan hälften behöll sin vikt

Att avsluta medicinering med GLP‑1‑läkemedel behöver inte innebära att man går upp i vikt igen. I en stor amerikansk studie behöll nästan hälften av patienterna...